BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38471082)

  • 1. ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis.
    Qiu Y; Wang X; Sun Y; Jin T; Tang R; Zhou X; Xu M; Gan Y; Wang R; Luo H; Liu M; Tang X
    Cancer Res; 2024 Jun; 84(11):1856-1871. PubMed ID: 38471082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
    Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
    PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
    Chen IH; Chang FR; Wu YC; Kung PH; Wu CC
    Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
    Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
    Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer.
    Rana PS; Wang W; Markovic V; Szpendyk J; Chan ER; Sossey-Alaoui K
    Cancer Res Commun; 2023 Jan; 3(1):160-174. PubMed ID: 36968231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
    Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
    J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
    Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
    Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer.
    Zhang Y; Sun L; Li H; Ai L; Ma Q; Qiao X; Yang J; Zhang H; Ou X; Wang Y; Chen G; Xue J; Zhu X; Zhao Y; Yang Y; Liu C
    Elife; 2022 Mar; 11():. PubMed ID: 35285795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
    Castillo AF; Orlando UD; Maloberti PM; Prada JG; Dattilo MA; Solano AR; Bigi MM; Ríos Medrano MA; Torres MT; Indo S; Caroca G; Contreras HR; Marelli BE; Salinas FJ; Salvetti NR; Ortega HH; Lorenzano Menna P; Szajnman S; Gomez DE; Rodríguez JB; Podesta EJ
    Cell Mol Life Sci; 2021 Mar; 78(6):2893-2910. PubMed ID: 33068124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
    Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.
    Wang Z; Li Y; Xiao Y; Lin HP; Yang P; Humphries B; Gao T; Yang C
    Int J Cancer; 2019 Nov; 145(10):2767-2780. PubMed ID: 31008533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
    Evans R; Flores-Borja F; Nassiri S; Miranda E; Lawler K; Grigoriadis A; Monypenny J; Gillet C; Owen J; Gordon P; Male V; Cheung A; Noor F; Barber P; Marlow R; Francesch-Domenech E; Fruhwirth G; Squadrito M; Vojnovic B; Tutt A; Festy F; De Palma M; Ng T
    Cell Rep; 2019 May; 27(7):1967-1978.e4. PubMed ID: 31091437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.